Dr. Andrew Einstein’s work aims to improve the balance of benefits and risks in medical imaging and intervention. As a cardiologist, he has a particular interest in cardiovascular procedures and in radiological protection. X-ray and nuclear medicine studies provide innumerable benefits to patients and their physicians, offering valuable diagnostic and prognostic information, affecting medical therapy, guiding interventions, and ultimately improving patient and societal outcomes. Nevertheless, their phenomenal growth has resulted in their becoming the largest source of ionizing radiation to the American population, and published estimates suggest that this burden may be responsible for tens of thousands of cancers each year. Dr. Einstein and his colleagues are involved in numerous research efforts aimed at better quantifying the radiation burden from these procedures, as well as developing and validating approaches to reduce radiation risk to patients and populations. This interdisciplinary program draws upon diverse fields, including radiobiology, medical physics, clinical cardiology, cancer epidemiology, outcomes research, and clinical trials. It has been recently funded by grants from the National Heart, Lung, and Blood Institute, the Margaret Q. Landenberger Foundation, the Louis V. Gerstner, Jr., Scholars Program, a Victoria and Esther Aboodi Assistant Professorship, a Herbert Irving Assistant Professorship, and investigator-initiated grants from industry. This work has resulted in numerous publications in journals such as the New England Journal of Medicine, the Journal of the American Medical Association, and the Lancet, has been widely reported in the popular media including the New York Times, the Wall Street Journal, and CBS Evening News, and has been influential in affecting clinical practice.
Andrew J. Einstein, MD, PhD